BR112022009539A2 - 6-hidroxi canabidiol para uso, composição para uso como medicamento, e, processo - Google Patents
6-hidroxi canabidiol para uso, composição para uso como medicamento, e, processoInfo
- Publication number
- BR112022009539A2 BR112022009539A2 BR112022009539A BR112022009539A BR112022009539A2 BR 112022009539 A2 BR112022009539 A2 BR 112022009539A2 BR 112022009539 A BR112022009539 A BR 112022009539A BR 112022009539 A BR112022009539 A BR 112022009539A BR 112022009539 A2 BR112022009539 A2 BR 112022009539A2
- Authority
- BR
- Brazil
- Prior art keywords
- cbd
- cannabidiol
- drug
- composition
- hydroxy
- Prior art date
Links
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 title abstract 8
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 title abstract 8
- 229950011318 cannabidiol Drugs 0.000 title abstract 8
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 title abstract 8
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229930003827 cannabinoid Natural products 0.000 abstract 3
- 239000003557 cannabinoid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
6-HIDROXI CANABIDIOL PARA USO, COMPOSIÇÃO PARA USO COMO MEDICAMENTO, E, PROCESSO. A presente invenção refere-se a um composto canabinoide do tipo canabidiol (CBD) para uso como medicamento. O canabinoide do tipo CBD, 6-hidroxi canabidiol (6-OH CBD), é um metabólito do CBD. O canabinoide pode ser produzido por meios sintéticos e um método para a produção de 6-OH CBD é descrito neste documento. Além disso, são descritos neste documento dados que demonstram a eficácia do 6-OH CBD em um modelo de doença.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1916974.7A GB201916974D0 (en) | 2019-11-21 | 2019-11-21 | Cannabidol-type cannabinoid compound |
| PCT/GB2020/052942 WO2021099781A1 (en) | 2019-11-21 | 2020-11-18 | Cannabidiol-type cannabinoid compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022009539A2 true BR112022009539A2 (pt) | 2022-08-02 |
Family
ID=69137192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022009539A BR112022009539A2 (pt) | 2019-11-21 | 2020-11-18 | 6-hidroxi canabidiol para uso, composição para uso como medicamento, e, processo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230000789A1 (pt) |
| EP (1) | EP4061344B1 (pt) |
| JP (1) | JP2023503303A (pt) |
| KR (1) | KR20220103996A (pt) |
| CN (1) | CN114786656A (pt) |
| AU (1) | AU2020389360A1 (pt) |
| BR (1) | BR112022009539A2 (pt) |
| CA (1) | CA3158182A1 (pt) |
| GB (2) | GB201916974D0 (pt) |
| IL (1) | IL293033A (pt) |
| MX (1) | MX2022005995A (pt) |
| TW (1) | TW202132249A (pt) |
| WO (1) | WO2021099781A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| WO2022238707A1 (en) * | 2021-05-12 | 2022-11-17 | GW Research Limited | Rescorcinols, methods for their manufacture, and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002512188A (ja) * | 1998-04-21 | 2002-04-23 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 抗酸化剤及び神経保護剤としてのカンナビノイド類 |
| GB2514054A (en) * | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| US10441617B2 (en) | 2013-03-15 | 2019-10-15 | Biotech Institute, Llc | Breeding, production, processing and use of medical cannabis |
| GB2527599A (en) * | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
| GB2548873B (en) * | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
| GB2572125B (en) * | 2018-01-03 | 2021-01-13 | Gw Res Ltd | Pharmaceutical |
-
2019
- 2019-11-21 GB GBGB1916974.7A patent/GB201916974D0/en not_active Ceased
-
2020
- 2020-11-18 CN CN202080080989.5A patent/CN114786656A/zh active Pending
- 2020-11-18 EP EP20815902.0A patent/EP4061344B1/en active Active
- 2020-11-18 US US17/777,681 patent/US20230000789A1/en active Pending
- 2020-11-18 GB GB2018135.0A patent/GB2591567B/en active Active
- 2020-11-18 AU AU2020389360A patent/AU2020389360A1/en active Pending
- 2020-11-18 KR KR1020227020682A patent/KR20220103996A/ko unknown
- 2020-11-18 JP JP2022529670A patent/JP2023503303A/ja active Pending
- 2020-11-18 WO PCT/GB2020/052942 patent/WO2021099781A1/en active Application Filing
- 2020-11-18 CA CA3158182A patent/CA3158182A1/en active Pending
- 2020-11-18 IL IL293033A patent/IL293033A/en unknown
- 2020-11-18 BR BR112022009539A patent/BR112022009539A2/pt unknown
- 2020-11-18 MX MX2022005995A patent/MX2022005995A/es unknown
- 2020-11-20 TW TW109140701A patent/TW202132249A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220103996A (ko) | 2022-07-25 |
| GB2591567A (en) | 2021-08-04 |
| CN114786656A (zh) | 2022-07-22 |
| GB2591567A9 (en) | 2021-12-15 |
| WO2021099781A1 (en) | 2021-05-27 |
| TW202132249A (zh) | 2021-09-01 |
| JP2023503303A (ja) | 2023-01-27 |
| EP4061344A1 (en) | 2022-09-28 |
| US20230000789A1 (en) | 2023-01-05 |
| GB201916974D0 (en) | 2020-01-08 |
| EP4061344B1 (en) | 2024-05-29 |
| MX2022005995A (es) | 2022-06-17 |
| IL293033A (en) | 2022-07-01 |
| AU2020389360A1 (en) | 2022-06-23 |
| GB202018135D0 (en) | 2020-12-30 |
| CA3158182A1 (en) | 2021-05-27 |
| GB2591567B (en) | 2022-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022009580A2 (pt) | 6-hidroxi canabidivarina para uso, composição para uso como medicamento, e, processo | |
| CL2017003245A1 (es) | Derivados de piperidina 1,4-sustituidos | |
| DOP2016000140A (es) | Inhibidores de syk | |
| BR112022009539A2 (pt) | 6-hidroxi canabidiol para uso, composição para uso como medicamento, e, processo | |
| CU20170172A7 (es) | 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos | |
| DOP2013000030A (es) | Compuesto heterociclico y su uso | |
| BR112015021856A2 (pt) | processos e intermediários para a preparação de um medicamento | |
| BR112018014536A2 (pt) | derivados de amônio, um processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| BR112015032921A8 (pt) | compostos de benzofuranila e benzoxazolila substituídos e utilizações dos mesmos | |
| EA202191427A1 (ru) | Каннабиноидное соединение типа каннабидиола | |
| BR112016007396A2 (pt) | derivados de cetona pirídicos, método de preparação dos mesmos e aplicação farmacêutica dos mesmos | |
| BR112016013493A2 (pt) | molécula de ácido nucleico, composição, vacina, e, métodos para prevenção de uma doença em um indivíduo com necessidade da mesma e para tratamento de uma doença em um indivíduo com necessidade do mesmo | |
| BR112015031913A2 (pt) | processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização | |
| CR20160072A (es) | Compuestos y composiciones como inhibidores de la mek | |
| UY30292A1 (es) | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor b(beta)2 adrenérgico | |
| CO6470845A2 (es) | Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales | |
| DOP2017000191A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| BR112015004089A2 (pt) | micro-organismos e métodos para intensificar a disponibilidade de equivalentes de redução na presença de metanol e para produzir 1,4-butanodiol relacionado com os mesmos | |
| BR112015002464B8 (pt) | processo para a preparação de carbamat-benzoxazinona, carbamat-benzoxazinona e uso da carbamat-benzoxazinona | |
| BR112015023241A2 (pt) | compostos inovadores de benzenossulfonamida, método para a sua sintetização, e sua utilização em medicina e, também, em cosméticos | |
| MX2020004232A (es) | Composiciones de cannabinoides y sus metodos de uso. | |
| Saleem et al. | A cross sectional study on work related musculoskeletal disorders among software professionals. | |
| CL2017000105A1 (es) | Novedosas pirimidinas 2,5-sustituidas. | |
| CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
| BRPI0816868A8 (pt) | Processo para a preparação de derivados de 2,2-difluoroetilamina, intermediários, seu uso e seu processo de preparação |